BP and Drug Manufacturers Dominate Federal Misconduct Penalties List
BP’s $34.3 billion in penalties, most stemming from the Deepwater Horizon disaster in 2010, account for 37% of all penalties paid, according to POGO. Next on the list is drug-maker GlaxoSmithKline, with more than $10 billion in penalties for unsafe drugs, financial irregularities, and illegal marketing practices.
The next eight companies on the list are either oil-related or drug companies, with two exceptions. They are drug companies Merck ($7.7 billion in penalties) and Pfizer ($5.2 billion); ExxonMobil ($2.9 billion); General Motors ($2.3 billion); oil services company Halliburton ($2.2 billion); drug company McKesson ($2 billion); health insurance giant UnitedHealth ($1.8 billion); and drug-maker Schering-Plough (merged with Merck) ($1.6 billion).
“Of the 17 different types of misconduct included in the database, labor and environmental violations are the most common, accounting for a combined 40 percent of the resolved instances,” wrote Neil Gordon at POGO. “Less than 7 percent of the instances of misconduct are criminal cases.”
To Learn More:
Big Pharma, Oil Dominate List of Federal Contractors Most Penalized for Misconduct (by Neil Gordon, Project on Government Oversight)
Federal Contractor Misconduct Database (Project on Government Oversight)
8 Corporations have Paid $1 Billion or more in Penalties in last 5 Years (by Noel Brinkerhoff and Steve Straehley, AllGov)
Most of $20.8 Billion BP Penalty Is Tax Deductible as a Cost of Doing Business (by Noel Brinkerhoff, AllGov)
Johnson & Johnson Ordered to Pay Billion-Dollar Penalty for Risperdal (by David Wallechinsky and Noel Brinkerhoff, AllGov)
Big 5 Defense Contractors Not Hurt by Their Multiple Cases of Misconduct (by Noel Brinkerhoff, AllGov)
- Top Stories
- Unusual News
- Where is the Money Going?
- U.S. and the World
- Appointments and Resignations
- Latest News
- Director of the Domestic Nuclear Detection Office: Who Is L. Wayne Brasure?
- Delegated Director, Substance Abuse and Mental Health Services Administration: Who Is Kana Enomoto?
- For Donald Trump, the Honeymoon was Over Before It Even Began
- Acting Director of the Indian Health Service: Who Is Mary L. Smith?
- Director of the Agency for Healthcare Research and Quality: Who Is Andrew Bindman?